On Mar. 16, 2013, the U.S. Patent and Trademark Office (USPTO) implemented the first inventor to file (FITF)…
On Feb. 22, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a…
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. U.S. Since mid-2011, a…
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
On Oct. 25, 2011, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Aug. 25, 2011, the Institute of Medicine issued the report titled “Review of Adverse Effects of Vaccines.”…
On Jun. 22, 2011, Sanofi Pasteur opened a $101 million dollar vaccine research and development facility at Sanofi…
On Jun. 11, 2011, scientists in China reported the isolation of 2 novel reassortant highly pathogenic avian influenza…
On May 19, 2011, the U.S. Centers for Disease Control and Prevention (CDC) hailed vaccinations as one of…
On Apr. 22, 2011, the U.S. Food and Drug Administration (FDA) approved the use of Menactra in children…
On Mar. 24, 2011, Zostavax, manufactured by Merck of Whitehouse Station, New Jersey, was approved by the U.S….
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
On Jul. 13, 2010, Bavarian Nordic announced that it had delivered 1 million doses of its smallpox vaccine…
On Mar. 22, 2010, the U.S. Food and Drug Administration (FDA) recommended that physicians temporarily suspend use of…
On Mar. 19, 2010, the Immunization Practices Advisory Committee (ACIP) recommended use of a reduced (4-dose) vaccine schedule…
On Feb. 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, a subsidiary of Pfizer])…
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…